{"id":"W4281647552","doi":"10.1200/jco.2022.40.16_suppl.5514","title":"A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Mesothelin; Bevacizumab; Internal medicine; Ovarian cancer; Paclitaxel; Oncology; Refractory (planetary science); Gastroenterology; Progression-free survival; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001759732,0.001592329,0.002036973,0.0004297161,0.0003850271,0.001068601,0.001008541,0.00145566,0.01056733],"category_scores_gemma":[0.001956875,0.000780253,0.001100453,0.0004024662,0.0008724307,0.0008648217,0.0004359496,0.002949623,0.001319531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001406364,"about_ca_system_score_gemma":0.001817965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002093124,"about_ca_topic_score_gemma":0.006119863,"domain_scores_codex":[0.9994364,0.0003279611,0.00002617943,0.00009379741,0.00003619863,0.0000793112],"domain_scores_gemma":[0.9990357,0.0002049813,0.0002130516,0.00008416655,0.0000509789,0.0004111138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9579249,0.01408841,0.0009431882,0.0004178508,0.0007466674,0.00007065146,0.00006776139,0.0005707557,0.004223381,0.0001748369,0.002470474,0.01830113],"study_design_scores_gemma":[0.9407592,0.05567839,0.001525093,0.00001840458,0.0002241519,0.00003564581,0.00001574939,0.0003702534,0.0002017494,0.0001261542,0.001035237,0.000009834349],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767572,0.002866324,0.0008011603,0.001109736,0.000645076,0.01031223,0.002740405,0.0001991699,0.004568585],"genre_scores_gemma":[0.9705936,0.001967121,0.002144078,0.002167481,0.0003800612,0.01105821,0.003681725,0.00005257615,0.007955045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01056733,"threshold_uncertainty_score":0.03535128,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1638973166607192,"score_gpt":0.4917078680616668,"score_spread":0.3278105514009477,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}